Detected ·

Tectora Therapeutics

$55M—

Tectora Therapeutics launched with a $55M Series A to develop innovative therapies for immunology and inflammation, co-founded by Schrödinger, NEA, and RA Capital Management.

Website
—
LinkedIn
—
Amount
$55 000 000 USD
Stage
—
Event
Funding round
Detected
2026-09-10 04:02:53 UTC
Signal ID
47ce75a1-ea49-4b43-ada1-93c9473f1ec3

As the API returns it

{
  "id": "47ce75a1-ea49-4b43-ada1-93c9473f1ec3",
  "created_at": "2026-09-10T04:02:53.552150Z",
  "company_name": "Tectora Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": 55000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Tectora Therapeutics launched with a $55M Series A to develop innovative therapies for immunology and inflammation, co-founded by Schrödinger, NEA, and RA Capital Management.*"
}

Latest rounds